Description
iXCells Biotechnologies offers CD3+ Pan T Cells from the human peripheral blood of individual healthy donors using negative immunomagnetic selection. These cells are untouched by the separation process and ready for downstream usage. > 86% of the cells are CD3+ as shown by flow cytometric analysis.
